WSJ: Teva close to CEO choice, with acting CEO and ex-Actavis chief still up for the job

Teva Pharmaceutical Industries ($TEVA) is said to be close to choosing Israeli executive Erez Vigodman to take its empty CEO chair, but as the Wall Street Journal reports, some other candidates are still in the running. Acting CEO Eyal Desheh is one of them, as is former Actavis ($ACT) CEO Claudio Albrecht, who stepped out of that company after its merger with Watson Laboratories. Report (sub. req.)